FDA approves new drug for severe asthma
On Nov. 4, the U.S. Food and Drug Administration (FDA) approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
